Differences Between Nephrotic and Nephritic Syndrome
Nephrotic syndrome and nephritic syndrome are distinct glomerular disorders with different clinical presentations, underlying causes, and management approaches.
Key Differences
| Feature | Nephrotic Syndrome | Nephritic Syndrome |
|---|---|---|
| Definition | Heavy proteinuria (>3.5g/24h), hypoalbuminemia (<3.0g/dL), edema, hyperlipidemia | Hematuria, proteinuria (usually non-nephrotic), hypertension, abnormal kidney function |
| Pathophysiology | Damage to podocytes and glomerular filtration barrier | Inflammation of glomeruli |
| Clinical Presentation | Peripheral edema, foamy urine, fatigue | Hematuria (tea/cola-colored urine), hypertension, oliguria |
| Prognosis | Variable depending on cause | Generally poorer than nephrotic syndrome [1] |
Causes of Nephrotic Syndrome
Primary Causes
- Minimal change disease (most common in children)
- Focal segmental glomerulosclerosis (FSGS)
- Membranous nephropathy
- Membranoproliferative glomerulonephritis
Secondary Causes
- Diabetes mellitus
- Systemic lupus erythematosus
- Amyloidosis
- HIV infection
- Medications (NSAIDs, gold, penicillamine)
- Malignancies
Causes of Nephritic Syndrome
Primary Causes
- Post-infectious glomerulonephritis
- IgA nephropathy (most common cause globally)
- Rapidly progressive glomerulonephritis
Secondary Causes
- Lupus nephritis
- ANCA-associated vasculitis
- Anti-glomerular basement membrane disease
- Cryoglobulinemia
- Henoch-Schönlein purpura
Diagnostic Approach
Nephrotic Syndrome
Laboratory evaluation:
- Urinalysis: Proteinuria, oval fat bodies, fatty casts
- 24-hour urine protein: >3.5g/24h
- Serum albumin: <3.0g/dL
- Lipid profile: Elevated cholesterol and triglycerides
- Renal function tests
Additional testing:
- Screen for secondary causes (diabetes, lupus, HIV)
- Genetic testing in suspected hereditary forms 2
Kidney biopsy:
- Indicated in adults with nephrotic syndrome without clear etiology
- May show diffuse foot process effacement in primary FSGS 3
Nephritic Syndrome
Laboratory evaluation:
- Urinalysis: Hematuria, red cell casts, proteinuria
- Complement levels (often low in post-infectious GN, lupus nephritis)
- ANCA, anti-GBM antibodies
- Renal function tests
Additional testing:
- Streptococcal antibody titers (ASO, anti-DNase B)
- ANA, anti-dsDNA for lupus
Kidney biopsy:
- Often necessary to determine specific cause and guide treatment
Management Approach
Nephrotic Syndrome
Supportive care:
- Edema management with diuretics
- ACE inhibitors or ARBs for proteinuria
- Statins for hyperlipidemia
- Anticoagulation in high-risk patients (albumin <20g/L) 2
Disease-specific therapy:
Nephritic Syndrome
Supportive care:
- Blood pressure control
- Management of acute kidney injury if present
Disease-specific therapy:
- Post-infectious GN: Antimicrobial therapy for underlying infection
- IgA nephropathy: ACE inhibitors/ARBs, consider corticosteroids for persistent proteinuria
- ANCA-associated vasculitis: Cyclophosphamide or rituximab plus corticosteroids 2
- Lupus nephritis: Mycophenolate mofetil or cyclophosphamide plus glucocorticoids 2
Common Pitfalls to Avoid
- Treating genetic forms of nephrotic syndrome with immunosuppression
- Inadequate thromboprophylaxis in high-risk nephrotic patients
- Overreliance on serum albumin levels alone for fluid management
- Failure to monitor for infections in immunosuppressed patients
- Delaying genetic testing in suspected congenital/infantile cases 2
Monitoring
Regular monitoring should include:
- Body weight and blood pressure
- Renal function (eGFR, serum creatinine)
- Proteinuria
- Serum albumin
- Urinary sediment
- Growth velocity in pediatric patients 2
Response assessment should evaluate for complete response (return of serum creatinine to baseline and decline in proteinuria) or partial response (stabilization of serum creatinine but persistent proteinuria) 2.